Clinical trialNCT06014502RecruitingPhase 1Interventional

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

SponsorImmunoGenesisEnrollment105Solid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
Madappa Kundranda, MD
Recruiting
Sarcoma Oncology Center
Santa Monica, California, United States
Neal S. Chawla, MD
Recruiting
St. Elizabeth Healthcare
Edgewood, Kentucky, United States
Daniel Flora, MD
Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Daniel Johnson, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
David S. Hong, MD
Recruiting
Next Dallas
Irving, Texas, United States
Shiraj Sen, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

IMGS-001

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Sept 2023
Primary completion: 31 Dec 2026
Completion: 31 Dec 2027
Last update posted: 8 May 2026
Registered enrollment: 105
Registry id: NCT06014502

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.